These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 856614)

  • 1. Some effects of mazindol, an anorectic drug, on rat brain monoaminergic systems.
    Sugrue MF; Shaw G; Charlton KG
    Eur J Pharmacol; 1977 Apr; 42(4):379-85. PubMed ID: 856614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
    Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
    Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the selective inhibition of serotonin uptake in vivo by Org 6582.
    Sugrue MF; Goodlet I; Mireylees SE
    Eur J Pharmacol; 1976 Nov; 40(1):121-30. PubMed ID: 991921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.
    Heikkila RE; Cabbat FS; Mytilineou C
    Eur J Pharmacol; 1977 Oct; 45(4):329-33. PubMed ID: 923643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):1-5. PubMed ID: 882144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on maxindol as an amine uptake inhibitor.
    Fuller RW; Snoddy HD; Wong DT; Bymaster FP
    Commun Psychopharmacol; 1978; 2(3):223-30. PubMed ID: 699537
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chlordiazepoxide administration on biogenic amines in cat brain.
    Vachon L; Roberge AG
    Can J Physiol Pharmacol; 1983 Jan; 61(1):81-8. PubMed ID: 6188521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1979 Mar; 31(3):183-4. PubMed ID: 34697
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography.
    Javitch JA; Strittmatter SM; Snyder SH
    J Neurosci; 1985 Jun; 5(6):1513-21. PubMed ID: 4009243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
    Kruk ZL; Zarrindast MR
    Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid (CSF) and brain monoamine metabolites in the developing rat pup.
    Shaywitz BA; Anderson GM; Cohen DJ
    Brain Res; 1985 Jan; 349(1-2):225-32. PubMed ID: 2580600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat.
    Bürki HR; Ruch W; Asper H
    Psychopharmacologia; 1975; 41(1):27-33. PubMed ID: 235767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):227-32. PubMed ID: 600310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mazindol on rat brain synaptosomal monoamine uptake.
    Sugrue MF; Mireylees SE
    Biochem Pharmacol; 1978; 27(14):1843-7. PubMed ID: 708465
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo (2, 1-a) isoindole (mazindol, SaH 42-548) on the metabolism of brain norepinephrine.
    Engstrom RG; Kelly LA; Gogerty JH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):308-21. PubMed ID: 1156036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.